0;object precari employ pe term use non standard employ form character low secur neg effect mental health object review systemat review evid effect pe mental health identifi import area research method protocol develop follow prisma p guidelin web scienc pubm psycinfo search septemb uniqu record assess elig qualiti review data includ studi summar forest plot meta analys use random effect model evid qualiti rate use grade method result obtain uniqu record studi suffici qualiti met inclus criteria moder qualiti evid grade score advers effect job insecur mental health summari odd ratio or confid interv ci low qualiti grade evid effect temporari employ unpredict work hour mental health studi multidimension exposur show advers effect weight averag ci conclus research pe mental health grow high qual prospect studi scarc job insecur like advers effect mental health clear multi dimension definit pe lack harmon effort need single vari observ studi job insecur temporari employ priorit
1;high parent self efficaci pse associ healthi diet higher level physic activ pa children howev data pse relat bodi weight bodi composit scarc object studi investig associ pse measur diet pa bodi composit physic fit earli childhood use baselin data ministop trial healthi swedish children n year pse assess use questionnair dietari data collect use mobil technology assist methodolog pa obtain sedentari behavior moderate to vigor accelerometri bodi composit measur use pediatr option bodpod cardiorespiratori fit m shuttl run linear regress conduct evalu cross sect associ outcom relat total pse score comput individu pse factor diet limit set unhealth behavior pa higher score total pse diet factor associ higher fruit intak β g point g point p respect lower consumpt unhealthi snack β g point g point p respect adjust parent bodi mass index educ respond child s sex age associ observ pse pa bodi composit cardiorespiratori fit studi note pse consid conjunct strategi sustain impact childhood obes
2;fine scal inform urban veget social ecolog relationship crucial inform urban plan ecolog research high spatial resolut imageri valuabl tool assess urban area howev urban ecolog remot sens larg focus citi temper zone goal character urban veget cover sub met m resolut aerial imageri identifi social ecolog relationship urban veget pattern tropic citi san juan metropolitan area puerto rico specif object map veget cover use sub met spatial resolut m imageri quantifi residenti non residenti veget investig relationship pattern urban veget vs socioeconom environment factor san juan metropolitan area green combin high spatial resolut imageri object bas classif highli success extract veget cover moist tropic citi accuraci addit simpl spatial pattern analysi allow separ residenti non residenti veget accuraci pattern residenti non residenti veget vari greatli citi socioeconom e g popul densiti build age detach home environment variabl e g topographi import explain variat veget cover spatial regress model howev import socioeconom driver citi temper zone incom home valu import san juan climat cultur differ tropic temper citi result differ social ecolog relationship studi provid novel inform local land use planner highlight valu high spatial resolut remot sens data advanc ecolog research urban plan tropic citi emphas need studi tropic citi
3;cdc recommend number mitig behavior prevent spread sars cov viru caus coronaviru diseas covid behavior includ cover nose mouth mask protect possibl infect public set person live outsid one s household ill household member maintain feet meter distanc person live outsid one s household keep oneself distant person ill wash hand soap water second or soap water avail use hand sanit contain alcohol age posit associ mask use known recommend mitig behavior monitor mitig behavior cours pandem inform target commun behavior modif strategi slow spread covid data foundat covid impact survey collect nation repres data report mitig behavior april jun adult unit state age year report use face mask increas april may reach june howev report mitig behavior e g hand wash social distanc avoid public crowd place declin margin remain unchang time point preval report mitig behavior lowest younger adult age year highest older adult age year lower engag mitig behavior younger adult reason increas incid confirm covid case group shown preced increas year find underscor need priorit clear target messag behavior modif intervent especi young adult encourag uptak support mainten recommend mitig behavior prevent spread covid
4;diabet drug metformin recent shown possess anti canc properti use chemotherapeut drug howev detail mechan metformin improv cancer treatment poorli understood provid evid hepg hepatocellular carcinoma cell metformin sensit cisplatin resist hepg cell hepg ddp increas cellular glycolysi suppress nrf depend transcript metformin increas glucos uptak enhanc glucos metabol glycolyt pathway result elev concentr intracellular nadph lactat consist high glucos medium suppress nrf depend transcript sensit hepg ddp cell cisplatin elev glycolysi requir metformin regul nrf depend transcript cisplatin sensit inhibit glycolysi deoxy d glucos dg significantli mitig benefici effect metformin togeth studi reveal import biolog process gene transcript program underli benefici effect metformin reduc chemo resist hepg cell provid new inform improv chemotherapi liver cancer
5;polyphenol long recogn health promot entiti includ benefici effect cardiovascular diseas reput boost recent follow number encourag clinic studi multipl chronic patholog valid efficaci health benefit polyphenol link well establish power antioxid activ review aim provid comprehens up to d knowledg current therapeut statu polyphenol have suffici heed treatment cardiovascular diseas furthermor data safeti profil highli efficaci polyphenol investig enhanc role cardiac abnorm evid present support action phenol deriv cardiovascular patholog follow receptor signal pathway ultim caus chang endogen antioxid antiplatelet vasodilatori anti inflammatori activ addit vitro antioxid pre clin clinic experi anti inflammatori immunomodulatori attribut polyphenol reveal role cardioprotect agent howev obviou shortag vivo studi relat dose select toxic polyphenol make compound suitabl target clinic investig studi need develop safe potent herbal product cardiovascular diseas novelti review provid comprehens knowledg polyphenol safeti health claim help research identifi moieti like exert protect therapeut effect cardiovascular diseas
6;cell express famili inositol hexakisphosph kinas ip k share enzymat activ individu ip k mediat differ cellular process report ip k enrich lead edg migrat cell associ dynein intermedi chain dic use immunofluoresc microscopi total intern reflect fluoresc microscopi dic ip k recruit interdepend lead edg migrat cell function coordin enhanc turnov focal adhes delet ip k caus defect cell motil neuron dendrit growth eventu lead brain malform result reveal mechan ip k function coordin dic confin intracellular microenviron promot focal adhes turnov
7;ecolog biomechan play central role gener phenotyp divers unrel taxa invad similar ecolog nich biomechan demand drive converg morpholog transform thu examin converg help elucid key catalyst phenotyp chang glide mammal present classic case converg evolut independ evolv numer clade possess patagia wing membran gener lift glide use phylogenet compar method test skelet morpholog clade extant glide mammal demonstr converg result indic glider skeleton converg glider group consist evolv proport longer gracil limb arborealist like increas patagi surfac area nonetheless interpret glider repres incomplet converg evolutionari model fit analys indic strong select pressur glider trait optima marsupi glider group diverg converg glide group remain separ morphospac rather converg singl morphotyp reflect unexpectedli high level morpholog dispar glider skeleton morpholog divers demonstr fossil glider mesozo era possess uniqu skelet characterist absent extant glider glider morpholog strongli influenc factor bodi size attach locat patagia forelimb vari clade thu converg glider appear driven simpl lengthen limb addit skelet trait reflect nuanc glide apparatu distinct differ evolutionari lineag unexpect result add grow evid incomplet converg preval vertebr clade classic case converg highlight import examin form funct relationship light phylogeni biomechan fossil record
8;sinonas mucos melanoma snmm rare tumor compris sinonas malign snmm frequent occur nasal caviti maxillari sinu typic black patch overal snmm harbor poor prognosi year surviv nasal caviti tumor confer better prognosi sinu melanoma primari manag snmm surgeri feasibl follow adjuv radiotherapi recent studi suggest immunotherapi confer surviv benefit patient advanc diseas multidisciplinari team approach shown optim treatment reduc cost minim advers event maxim chanc cure
9;suppli phytolith rich biochar agrosystem increas soil ph cec nutrient avail ad impact si uptak plant growth studi specif impact influenc soil properti assess role phytolith provid plant avail si use young cambisol highli weather poorli buffer desil nitisol biochar produc rice plant respect enrich si deplet si si ident ph nutrient content larg differ si content g si kg si vs g si kg si compar effect wollastonit casio biomass mineralomass wheat plant soil solut plant devic content soil bioavail si biogen si assess origin cacl kinet extract demast na co alkalin dissolut respect demast techniqu dissolv si phytolith wollastonit soil buffer capac cmolc kg cambisol nitisol ident suppli phytolith biochar increas ph cambisol ni increas content bioavail si from mg kg cambisol mg kg nitisol plant si uptak biomass si mineralomass increas largest nitisol demast techniqu did specif quantifi phytolith pool pool main sourc plant avail si cambisol nitisol amend phytolith biochar ident phytolith si suppli howev soil ph soil buffer capac control transfer si soil plant system largest poorli buffer nitisol effect phytolith biochar si bioavail depend soil constitu properti soil type
10;neg interact speci gener diverg select caus charact displac howev process caus similar diverg use spatial tempor replic island popul anoli lizard assess import neg interact drive trait shift previou work show establish anoli sagrei island drove resid anoli carolinensi perch higher evolv larger toepad test interact s causal predict resurvey subset island year later anoli sagrei establish island survey a carolinensi island perch higher larger toepad howev toepad morpholog chang island distinct shift island anoli commun composit chang thu presenc a sagrei partli explain a carolinensi trait variat space time a carolinensi island previous establish a sagrei perch higher decad ago current a carolinensi perch height correl a sagrei densiti result suggest charact displac like interact evolutionari process system tempor data key detect interact
11;scholar interest relationship social context health recent turn attent upstream understand polit social econom institut shape distribut life chanc context compar minor health inequ european countri n investig arrangements welfar state effort immigr incorpor policies influ distribut health health inequ examin measur health seven wave european social survey result seri multilevel mixed effect model minor health inequ vari context persist account socioeconom differ cross level interact result welfar state effort associ better health group unrel level inequ group contrast polici aim protect minor discrimin correl smaller rel health inequ
12;congenit nonunion clavicl well known patholog children posttraumat nonunion rare entiti nonunion open reduct intern fixat clavicl fractur except pediatr popul report patient present posttraumat pseudarthrosi clavicl surgic treatment pseudarthrosi resect defect bridg iliac crest autograft supplement bone morphogenet protein fix elast stabl intramedullari nail procedur offer stabil achiev fractur consolid safe altern plate clavicl nonunion
13;non smal cell lung cancer nsclc largest type lung cancer lc higher mortal rate circular rna circrna shown play import role cancer progress therefor studi explor function hsa circ nsclc express level hsa circ microrna p mir p forkhead box p foxp determin quantit real tim polymeras chain reaction qrt pcr ribonucleas r rnase r actinomycin d actd use verifi authent stabil hsa circ cell count kit cck flow cytometri transwel assay use evalu abil prolifer apoptosi migrat invas nsclc cell also western blot wb analysi perform assess level apoptosi epithelial mesenchym transit emt proliferation rel protein foxp protein rna immunoprecipit rip dual luciferas report assay use verifi interact mir p hsa circ foxp besid mice xenograft model construct confirm effect hsa circ nsclc tumor growth vivo hsa circ lowli express nsclc tissu cell overexpress inhibit prolifer migrat invas emt process improv apoptosi nsclc cell mir p spong hsa circ overexpress invert suppress effect overexpressed hsa circ nsclc progress moreov foxp target mir p silenc revers inhibit effect overexpressed hsa circ nsclc progress addit hsa circ overexpress reduc tumor growth nsclc vivo hsa circ spong mir p improv foxp express inhibit nsclc progress studi show hsa circ potenti biomark earli diagnosi nsclc
14;atherosclerosi major cardiovascular diseas caus ischemia heart brain extrem lead infarct hypolipidem agent atorvastatin calcium ato allevi atherosclerosi reduc plasma lipid inflammatori factor howev low bioavail ato limit widespread use clinic effect curcumin cur natur polyphenol antioxid anti inflamm bioactiv potenti anti atherosclerosi activ reduc ato induc cytotox liposom modifi use target ligand e selectin bind peptid prepar co deliv ato cur dysfunct endotheli cell ec overexpress e selectin molecul involv inhibit adhes e selectin intercellular cell adhes molecule icam inflamm il monocyt chemotact protein mcp human aortic endotheli cell evalu use real tim quantit pcr flow cytometri immunofluoresc stain antiatherosclerosi effect liposom co load ato cur vivo evalu use apo knockout apoe mice target liposom deliv ato cur dysfunct ec result synergist suppress adhes molecul e selectin icam plasma lipid level moreov treatment reduc foam cell format secret inflammatori factor il mcp block monocyt migrat intima addit cur success reduc ato induc cytotox vitro vivo experi demonstr cell target co deliveri ato cur dysfunct ec drastic reduc atherosclerot lesion fewer effect ato cur alon
15;caus dispar biodivers region fundament question biogeographi ecolog evolutionari biolog evolutionari biogeograph process speciat extinct dispers directli determin speci rich pattern studi use integr phylogenet approach howev strikingli high rich east asia rel northern hemispher region remain poorli understood perspect here time test gener hypothes older colon time faster diversif rate explain pattern use plant tribe lysimachiea primulacea model system gener new time calibr phylogeni lysimachiea gene speci estim colon time diversif rate region test rel import factor explain region rich pattern time diversif rate explain rich pattern region lysimachiea instead new index combin factor explain global rich pattern group high east asian biodivers base result lysimachiea suggest high rich plant east asia explain combin older colon time faster diversif rate region
16;radium ra prolong surviv improv qualiti life men metastat castration resist prostat cancer mcrpc bone howev compar mcrpc therapi use ra come uniqu challeng henc aim identifi ra util pattern real world condit factor predict treatment complet outcom retrospect chart analysi mcrpc patient identifi receiv ra outsid clinic trial access program januari octob cancer centr ontario main outcom studi ra complet rate reason earli treatment discontinu overal surviv surviv differ patient complet ra therapi versu patient receiv cycl ra addit patient diseas characterist analys identifi predictor treatment complet surviv cohort patient pretreat abirateron and or enzalutamid half receiv docetaxel ra complet rate actuari median surviv month main reason earli ra discontinu diseas progress ra non complet associ poorer outcom median surviv month versu month men complet ra p lymph node metastas high baselin prostate specif antigen psa independ predictor earli treatment discontinu multivari cox proport hazard model reveal earli ra discontinu baselin anemia high psa prior skeletal rel event viscer metastas refer centr ra therapi predictor wors outcom despit lower complet rate observ clinic trial condit real world result achiev ra encourag prospect valid predict patient diseas characterist identifi cohort instrument identifi mcrpc patient like complet benefit ra therapi
17;visual signal attract friend attract enemi bright color anther pollen gener thought attract pollin hypothes visual crypsi anther particularli pollen favor flower plant protect pollen collector reduc loss male gamet understand adapt strategi relat color pollen measur color pollen undehisc anther sac background corolla spectromet insect pollin flower speci natur commun hengduan mountain southwest china color anther pollen corolla divers speci color divers expos pollen significantli higher conceal pollen i e anther enclos shield corolla color contrast pollen corolla significantli smaller speci expos pollen conceal pollen unlik anther color expos pollen color tend match background corolla color phylogenet compar analysi show contrast effect pollen color pattern flower expos pollen conceal pollen reveal strategi hide pollen pollen thiev visual crypsi
18;make research respons research outcom meaning necessari commun research involv relev stakehold possibl especi application oriented includ inform commun technolog ict research nowaday stakehold engag fundament import project success achiev expect impact mandatori third parti fund context ultim research develop success peopl react posit result benefit gener project wider accept research outcom essenti public awar opportun discuss result research undertaken two way commun interperson commun research respons research innov rri approach anticip assess potenti implic societ expect regard research innov aim foster inclus sustain research innov research innov process need respons adapt grand challeng impli thing introduct broader foresight impact assess new technolog anticip market benefit risk therefor articl provid structur workflow explain how develop stakehold engag plan step step
19;cyclin depend kinas cdk inhibitor revolution treatment landscap hormon receptor posit hr human epiderm growth factor receptor neg her metastat breast cancer impress efficaci safeti profil cytopenia main advers event predict manag here report case cdk inhibitor induc vitiligo lik lesion vitiligo vitiligo lik lesion rare advers event case report literatur year old femal patient diagnos initi early stag right breast cancer hr her treat breast conserv surgeri follow chemotherapi radiotherapi hormon therapi year later develop metastat diseas hilar lymph node multipl skelet site includ left scapula left shoulder left iliac bone dorsal vertebra treat ribociclib letrozol treatment develop hypopig lesion involv hand feet face describ vitiligo lik lesion cdk inhibitor induc vitiligo rare unpredict advers event case report highlight rariti advers event dilemma relat optim treatment decis relat continu hold switch cdk inhibitor
20;review result decad excav center melbourn australia provid opportun reflect archaeolog evid contribut understand coloni citi citi shape role coloni entrepot gold rush port nineteenth centuri metropolitan center rich archaeolog record deriv intersect heritag control develop boom data archaeolog excav drive new perspect melbourn itself reveal citi intim connect gold rush boom fuell growth archaeolog data shed light specif distinct histor circumst influenc develop citi establish nineteenth centuri includ transnat migrat trade emerg concern public health sanit
21;question probabilist opinion differ individu aggreg form group opinion controversi assumpt pretti common ground group bayesian represent group opinion uniqu probabl distribut madanski lehrer wagner mcconway journal american statist associ bordley manag scienc genest et al annal statist genest zidek statist scienc mongin journal econom theori clemen winkler risk analysi dietrich list herzberg theori decis argu assumpt order extend canon mathemat framework pool cover pool imprecis probabl ip employ set valu pool function gener common pool axiom accordingli proof concept ip construct satisfi number central pool axiom jointli satisfi standard pool recip pain trivial follow levi synthes argu ip model admit better philosoph motiv model ration consensu
22;close relat speci substanti differ ecolog trait allow occupi differ environment nich system clear genom basi adapt loci major effect genome wid differ drive speci diverg cryptic speci tabletop coral acropora hyacinthu broadli sympatr american samoa common speci differ key environment trait microhabitat distribut thermal stress toler compar gene express pattern genet polymorph speci use rna seq vast major polymorph share speci speci widespread differ allel frequenc gene express tend host differ symbiont type chang gene express relat chang frequenc gene regulatori variant differ consist action genet drift howev observ greater genet diverg speci amino acid replac polymorph compar synonym variant find suggest polygen evolut play major role drive speci differ ecolog resili climat chang
23;aim studi review publish literatur address question geriatr assess ga routin appli treatment older adult esophag cancer ec receiv definit concurr chemoradiotherapi dcrt literatur search pubm embas cochran librari perform studi contain origin data outlin inclus exclus criteria treatment complianc rate sever toxic report review addit criteria ongo clinic trial world health organ nation institut health registri review evalu util ga rel domain elderli ec patient receiv dcrt twenty nin studi identifi base select criteria single arm prospect studi studi retrospect studi studi use chronolog age perform statu basic descriptor subpopul comorbid index malnutrit level mention studi howev factor demograph data social support psycholog polypharmaci geriatr syndrom describ includ studi unfortun result similar regist clinic trial final treatment complianc toxic profil accept select elderli ec patient current experi older adult ec receiv dcrt mainli base result seri retrospect studi ongo clinic trial routin consid ga rel domain select appropri treatment patient futur
24;western amazonia global biodivers hotspot encompass extens variat geolog climat biotic featur palm arecacea divers icon group plant region speci exhibit extraordinari variat geograph distribut region abund pattern life histori strategi growth form provid myriad ecosystem servic understand ecolog evolutionari driver underpin palm distribut abund pattern shed light evolut ecolog tropic forest biom gener edaph condit particular increasingli recogn critic driver tropic plant divers distribut data defici inhibit understand plant soil relationship broad scale especi tropic present data ha m georeferenc transect locat western amazonia individu palm identifi count assign life histori stage environment covari record transect surfac soil sampl collect multipl point n transect altogeth transect includ individu belong speci variat transect term palm speci rich abund associ major habitat type soil properti soil properti includ ph acid macronutri sampl textur carbon nitrogen micronutri transect vari substanti studi area provid insight broad scal variat tropic surfac soil data provid help advanc understand plant distribut abund pattern associ soil condit copyright restrict associ data set cite paper data use public
25;polycyst ovari syndrom pco common endocrin disord high incid recent implic signific risk factor endometri cancer ec studi aim detect share gene signatur biolog mechan pco ec bioinformat analysi bioinformat analysi base geo databas consist data integr network construct function enrich analysi appli addit pharmacolog methodolog molecular dock perform total hub common gene mrpl mrpl mrps rpl l esr jun ube i mrpl rpl a gtf h consid share gene signatur ec pco kegg pathway analysi hub gene show mitochondri translat elong ribosom subunit structur constitu ribosom ribosom highli correl besid associ transcript factor tf mirna network construct identifi candid drug molecul includ fenofibr cinnarizin propanil fenthion clindamycin chloramphenicol demeclocyclin hydrochlorid azacitidin chrysen artenimol accord hub gene molecular dock analysi verifi good bind interact fenofibr avail target jun esr ube i gene signatur regulatori biolog pathway identifi bioinformat analysi moreov molecular mechan signatur explor potenti drug molecul associ pco ec screen out
26;purpos studi evalu prophylact effect quercetin que oxid damag histolog chang induc tetrachlorodibenzo p dioxin tcdd rat heart purpos adult male wistar rat divid group fellow control group tcdd group µg kg bw day gavag daili consecut day que group mg kg bw day tcdd quegroup oxid biomark heart tissu level ctni lipid profil serum measur result show ctni serum level heart lipid peroxid significantli increas heart level antioxid profil significantli decreas tcdd group compar control quegroup pretreat quecould significantli improv factor serum heart tissu anim consum tcdd conclud queat dose mg kg day allevi heart oxid damag histolog chang induc tcdd
27;epitheli tissu mechan deform surround extracellular matrix embryon develop wound repair tumor invas ex vivo measur multicellular traction three dimension d biomateri elucid collect dissemin diseas progress enabl preclin test target antimigr therapi howev past d traction measur low throughput challeng imag analyz information rich d materi deform here demonstr method profil multicellular cluster well plat format base spatial heterogen contractil protrus circumferenti traction case studi profil multicellular cluster vari state epithelial mesenchym transit reveal success loss protrus circumferenti traction format local contractil traction elong cluster morpholog cluster phenotyp biochem perturb use drug bias traction signatur differ epitheli mesenchym state higher throughput analysi promis systemat interrog perturb aberr mechanobiolog util human pati sampl guid person therapi
28;glacial lake outburst flood glof northern patagonian ice field affect baker river basin increas frequenc recent year evalu impact glof hydrographi biolog compon plankton baker fjord assess rel contribut terrigen versu marin plankton carbon sourc particul organ matter pom fjord glof austral summer evalu terrestri carbon brought fjord river reach higher trophic level deposit feed organ juvenil pelag munida gregaria day period hydrograph profil water sampl pom zooplankton sampl collect daili station depth fjord s inner section sampl suspend pom tissu m gregaria analyz stable isotop composit carbon δ c glof arriv produc thermal fjord follow oscil pycnoclin abrupt increas total organ carbon content pom attribut terrestri input concurr peak abund m gregaria suggest aggreg respons glof understand glof effect local hydrographi product food web structur provid valuabl insight potenti respons fjord ecosystem gener climat change induc variabl given present climat trend high latitud zone frequent glof expect patagonian fjord channel high latitud basin
29;inclus fit theori predict parent care vari related potenti care parent offspr potenti shape mate evolut system extra pair patern epp variabl parent brood related provid valuabl opportun test predict howev exist theoret empir studi assum focal male offspr s father inbreed complet unrel highlight simpl dichotomi doe hold given reproduct interact rel complic effect epp parent brood related provid new opportun test inclus fit theori accordingli test hierarch hypothes relat parent feed rate parent brood related parent kinship inbreed use song sparrow melospiza melodia experienc natur variat related predict male femal feed rate increas related depend brood control brood size male feed rate tend decreas patern loss increas increas increas kinship inbreed social pair mate demonstr variat key compon parent care concur subtl predict inclus fit theori addit highlight effect depend underli social mate system potenti gener status specif cost extra pair reproduct
30;aim phenomenolog studi explor princip famili member experi motiv patient chronic obstruct pulmonari diseas copd self manag interview conduct famili member spous adult children copd patient interview audio record transcrib analyz themat princip famili member copd patient character frustrat care want best him her carri heavier burden person feel equip for lack knowledg diseas progress inform avail healthcar resourc situat demand energi copd patient lack stamina famili member fear patient s possibl breathless willing help meet neg reaction patient feel ignor health profession hp famili member express need formal connect patient family hp increas burden experienc patient famili member character sequenti process phase patient s declin self manag earli phase famili patient ignor copd recogn patient s smoke riski lifestyl intermediari phase sign copd evid famili turn point famili observ patient s acut exacerb second turn point advanc phase famili patient recogn copd progress diseas possibl fatal identifi famili member view copd patient need role main frustrat concern famili member experi motiv copd patient self manag sequenti process famili experi advanc care burden declin self manag patient propos establish copd patient team consist patient family hp aim patient best possibl self manag
31;clarifi histolog basi bacillari layer detach balad review current literatur analysi retin imag literatur previou report balad review analysi retin imag perform support anatom conclus total uniqu patient balad optic coher tomographi oct identifi publish literatur twenty two underli etiolog associ subretin exud identifi forty on differ oct terminolog found defin oct featur balad split level photoreceptor inner segment myoid creat distinct intraretin caviti resolut balad follow rapid restor ellipsoid zone histolog age rel macular degener eye suggest individu photoreceptor shed inner segment furthermor detach entir layer inner segment common postmortem artifact propos balad occur outwardli direct forc promot attach photoreceptor outer segment retin pigment epithelium exceed tensil strength photoreceptor inner segment myoid review serv strengthen oct nomenclatur bacillari layer detach base specif reflect inform obtain oct previous publish histolog observ
32;cystatin c propos confirmatori test chronic kidney diseas ckd applic older individu ckd major creatinine bas estim glomerular filtrat rate egfr ml min m ckd stage a sought examin util cystatin c confirmatori test ckd age rang gener popul older adult cross sect analysi particip irish longitudin studi age cluster sampl nation cohort community dwel adult age year cystatin c creatinin measur simultan use standardis assay use generalis addit model model distribut creatinin cystatin c year age distribut paramet locat dispers skew kurtosi particip ckd stage a estim predict probabl cystatin c egfr ml min m confirm ckd function age median age year femal median cystatin c egfr ml min m observ progress variabl cystatin c increas age compar creatinin cystatin c level rose sharpli age particip ckd stage a n predict probabl confirm ckd increas steadili age age age clinic util cystatin c maximis middle ag individu distribut cystatin c variabl older adult pretest probabl confirm ckd lower
33;asn link oligosaccharid extens modifi transit secretori pathway trim nascent glycan chain subsequ initi extend multipl oligosaccharid branch trimannosyl glycan core trim branch pathway step highli order hierarch base precis substrat specif individu biosynthet enzym key commit step synthesi complex typ glycan catalyz n acetylglucosaminyltransferas ii mgat enzym gener second glcnacβ branch trimannosyl glycan core use udp glcnac sugar donor determin structur human mgat mn udp donor analog complex glcnacman glcnac asn acceptor complex reveal structur basi substrat recognit catalysi enzym exhibit gt a rossmann lik fold employ conserv dival cation depend substrat interact udp glcnac donor mgat interact extend glycan acceptor distinct relat glycosyltransferas interact compos catalyt subsit bind man α monosaccharid acceptor distal exosit pocket bind glcnac β man α manβ substrat recognit arm recognit arm interact similar enzyme substr interact golgi α mannosidas ii glycosid hydrolas act just mgat asn link glycan biosynthet pathway data suggest substrat bind mgat employ conserv converg catalyt subsit modul provid substrat select catalysi broadli mgat active sit architectur demonstr glycosyltransferas creat complementari modular templat regiospecif extens glycan structur mammalian cell
34;herg potassium channel enhanc tumor invas breast cancer prolifer microrna mirna dysregul cancer control gene regul object studi identifi mirna regul herg express breast cancer put mirna target herg identifi bioinformat approach screen use utr luciferas assay function assess endogen herg regul use whole cel electrophysiolog prolifer assay cell cycl analys follow mirna herg sirna control transfect mir p target herg utr associ higher surviv rate patient breast cancer hr ci enhanc mir p express reduc herg express peak current cell prolifer cultur breast cancer cell p mir p mediat transcript regul herg associ surviv breast cancer potenti mir p serv biomark inform therapeut strategi warrant investig
35;group individu compet multiple pr contest perform group vector order categori prize aim rank particip group perform trivial compar note provid theoret discuss rank group perform order so draw parallel problem formal similar problem measur inequ altern gener partial order group perform defin partial order base first second ord domin class perform measur set basic transform prove equival theorem them appli theoret result discuss sport rank problem
36;papillari thyroid carcinoma ptc common type thyroid malign case rise steadili worldwid past decad despit great progress have surgeri chemotherapi ptc surviv rate ptc patient increas significantli therefor urgent need explor novel treatment strategi level circrna mir a p il mrna ptc tissu cell examin qrt pcr assay cell prolifer ic valu oncolyt vaccinia viru ovv detect cck assay dual luciferas report assay perform detect relationship circrna mir a p il elisa carri detect express il circrna increas ptc tissu cell line act spong mir a p moreov knockdown mir a p suppress ovv medi antitumor effect cell prolifer ptc addit reveal circrna bound mir a p spong promot il express studi reveal high express oncogen function circrna ptc cell then circrna spong mir a p upregul il express result cell prolifer promot ovv medi antitumor effect enhanc strengthen viral replic provid new insight futur therapi ptc
37;myocardi infarct mi cardiac diseas high incid mortal worldwid long noncod rna lncrna play essenti role patholog progress variou cardiovascular diseas ilf as newli identifi lncrna studi demonstr ilf as affect develop variou malign howev biolog function ilf as underli mechan mi unknown present studi function ilf as possibl mechan hypoxia induc apoptosi h c cell investig h c cell expos hypoxia o mimic vitro model mi level lncrna ilf as microrna mir p measur real tim pcr rt pcr transfect perform upregul level ilf as mir p western blot assay carri measur protein express relationship ilf as mir p verifi dual luciferas report assay ilf as downregul hypoxia overexpress ilf as result relief hypoxia induc damag h c cell rescu cell viabil migrat invas suppress apoptosi downregul ilf as opposit effect moreov ilf as neg regul mir p express upregul ilf as allevi hypox injuri downregul mir p moreov mir p neg regul sirt express investig reveal ilf as activ pi k akt signal applic pi k inhibitor ly abrog protect effect ilf as hypoxia summari conclud ilf as provid protect hypoxia induc injuri pi k akt pathway provid clue treatment patient mi
38;object develop valid reliabl academ resili scale use didact portion doctor pharmaci curriculum identifi pharmaci student greater capac overcom academ advers method cross sect survey conduct first year second year third year pharmaci student assess psychometr properti item adapt academ resili scale data collect use short grit scale grit demograph characterist collect student record exploratori factor analysi appli determin number underli factor respons data covari princip compon analysi use extract method varimax rotat method use cronbach alpha estim valid test conduct calcul pearson s r correl adapt academ resili scale grit result survey respons rate final version scale academ pharmaci resili scale aprs subscal item item fail load factor delet cronbach alpha indic strong intern consist aprs subscal significantli correl grit subscal provid evid effect converg valid conclus evid support reliabl valid aprs measur academ resili pharmaci student futur studi use aprs investig relationship academ resili perform outcom pharmaci student
39;interleukin receptor alpha il r interact il form ligand receptor complex stimul variou cellular respons cell prolifer cell differenti activ inflammatori process genet mutat epigenet modif regul gene transcript identifi novel splice variant bovin il r design il r tv character skip exon ncbi referenc il r gene il r refer express level il r tv il r refer transcript lower normal mammari gland tissu transcript play potenti role inflammatori infect detect put function snp g t c g g c locat upstream bp exon snp form haplotyp t g c c mutant pspl exon trap plasmid pspl t g pspl c c transfer bovin mammari epitheli cell mac t human embryon kidney t cell hek t investig relationship snp aberr splice il r dna methyl level altern splice exon normal mastitis infect mammari gland tissu quantifi nest bisulf sequenc pcr bsp clone sequenc dna methyl regul il r transcript dna methyl level high mastitis infect mammari gland tissu stimul il r express promot inclus altern splice exon upregul express transcript dna methyl modif genet mutat
40;crispr cas power tool genom engin on target activ off target effect wide vari differ guid rna grna sequenc genom environ tradit approach reli separ model paramet treat on off target cleavag activ here demonstr free energi scheme domin cas edit efficaci delin method simultan consid on target activ off target effect data driven machine learn approach learn rule model particular dataset transferr new system capabl produc new mechanist insight principl physic approach integr energet r loop format cas bind effect protospac adjac motif sequenc fold stabil singl guid rna devis unifi physic model appli cleavage act dataset unifi framework improv predict on target activ off target effici spcas readili transfer system differ guid rna cas ortholog protein
41;dna encod chemic librari collect compound individu coupl uniqu dna tag serv amplifi identif barcod bridg split and pool combinatori synthesi ligat uniqu encod dna oligom million billion memb librari synthes use hundr healthcar target screen structur divers desir molecular properti rang gener guid dna encod chemic librari design recent report highlight util focus dna encod chemic librari structur bias class protein target herein protease focus dna encod chemic librari design util chemotyp known engag conserv catalyt proteas residu three cycl librari featur function moieti guanidin interact strongli aspart proteas catalyt triad mild electrophil sulfonamid urea carbam develop dna compat method guanidinyl amin reduct nitril employ optim reaction construct million memb dna encod chemic librari affin select librari thrombin common proteas reveal number enrich featur ultim led discoveri nm inhibitor thrombin thu structur focus dna encod chemic librari tremend potenti clinic use high affin hit rapid discoveri drug target e g proteas essenti function infecti diseas e g sever acut respiratori syndrom coronaviru relev healthcar condit e g male contracept
42;clinic studi suggest hydroxyvitamin d oh d defici play pivot role type diabet mellitu t dm cognit impair howev unclear oh d defici possibl caus cognit impair t dm vitamin d bind protein vdbp act major oh d transport preclin studi demonstr improv cognit function vdbp inhibit synapt degener aim studi assess associ serum oh d vdbp cognit impair t dm patient case control studi cognit function assess use mini ment state examin mmse serum oh d vdbp level estim use elisa kit total subject includ studi t dm patient lower serum oh d p vdbp level p mmse score p control t dm patient higher preval oh d defici insuffici aor p cognit impair aor p cognit impair associ serum oh d aor p vdbp aor p gener linear model show signific associ mmse serum oh d p serum oh d defici cognit impair higher t dm patient routin assess cognit function suggest prevent behavior complic associ vdbp cognit impair t dm need explor
43;studi aim determin preval anxieti clinic train student despit exist intervent address anxieti lack data size problem especi middl east mental health stigmat mean outcomesmay maxim studi cross sect survey univers sharjah uo unit arab emir student undergo clinic train health scienc particip select uo campus medic scienc colleg women s colleg men s colleg sampl clinic train student randomli sent electron link particip onlin survey studi receiv ethic approv uo research ethic committe number rec s mean score state anxieti mean score trait anxieti score indic high level anxieti student undertak clinic train overal sampl classifi have high state anxieti high trait anxieti studi show clinic train student experi high level state trait anxieti necessari address issu improv condit circumst student enter clinic train necessari implement strategi enabl student anxieti perform clinic train
44;prior research demonstr clear relationship experi racial microaggress variou indic psycholog unwel concern find role neg affect consid marker neurotic consid neg affect previous correl experi racial discrimin psycholog unwel suggest caus observ relationship microaggress psychopatholog examin relationship self report frequenc experi microaggress mental health outcom i e anxieti beck anxieti inventori stress gener ethnic discrimin scale trauma symptom trauma symptom discrimin scale african american european american colleg student control neg affect the posit neg affect schedul gender result indic african american experi racial discrimin european american neg affect african american appear significantli relat percept experi discrimin strong relationship racial mistreat symptom psychopatholog evid control neg affect summari african american experi clinic measur anxieti stress trauma symptom result racial mistreat wholli explain individu differ neg affect futur work examin addit factor relationship target intervent develop help suffer result racial mistreat reduc microaggress
45;studi aim explor underli mechan shenyankangfu tablet sykft treatment glomerulonephr gn base network pharmacolog machin learn molecular dock experiment valid activ ingredi potenti target sykft obtain tradit chines medicin system pharmacolog databas analysi platform target gn obtain genecard etc perl cytoscap use construct herb act ingredient target network then clusterprofil packag r use gene ontolog go kyoto encyclopedia gene genom kegg pathway analysi use string platform cytoscap construct protein protein interact ppi network swisstargetpredict server predict target protein core activ ingredi base machine learn model molecular dock analysi perform use autodock vina pymol final verifi effect sykft gn vivo total activ ingredi target sykft screen target identifi relat gn enrich analysi indic biolog process primarili associ oxid stress cell prolifer kegg pathway analysi show target involv infection rel gn relat pathway ppi network analysi identifi core target sykft result machine learn model suggest stat akt key target result molecular dock suggest main activ compon sykft combin variou target protein vivo experi confirm sykft allevi renal patholog injuri regul core gene reduc urinari protein studi demonstr time multicompon multitarget multipathway characterist sykft gn treatment
46;paper investig power migrat mechan transmiss social norm take mali femal genit mutil fgm case studi mali strong fgm cultur long stand histori migrat use origin household level databas coupl censu data analyz extent girl live local high rate return migrant prone fgm malian migrat predominantli african countri femal circumcis uncommon e g côte d ivoir countri fgm total ban franc develop countri anti fgm inform campaign frequent target african migrant take two step instrument variabl approach control endogen migrat return decis return migrant neg signific influenc fgm practic precis result primarili driven flow returne cote d ivoir adult live local return migrant inform fgm favor legisl impact returne occur channel includ composit effect chang return migrant attitud fgm return migrant convinc stayer chang fgm practic
47;evalu dynam earli serum tumour marker stm neutrophil to lymphocyt ratio nlr predict clinic efficaci prognosi advanc non small cel lung cancer nsclc patient receiv program cell death pd program cell death ligand pd l inhibitor retrospect review patient advanc nsclc treat pd pd l inhibitor septemb august nlr stm routin measur immunotherapi initi radiolog evalu combin score base lead stm nlr dynam chang establish effect lead stm chang nlr chang combin score object respons rate orr durabl clinic benefit dcb progression fre surviv pf overal surviv os analys accuraci combin score evalu receiv oper characterist roc curv area curv auc overal patient includ retrospect cohort studi orr dcb median os pf month respect patient low combin score significantli improv orr dcb compar intermedi high score p orr p dcb multivari model combin score independ indic pf p os p auc demonstr combin score auc greater predict power posttreat nlr auc lead stm chang auc alon easi cost effect novel combin score base dynam earli stm nlr accur predict clinic efficaci pd pd l inhibitor prognosi advanc nsclc patient
48;consolid natur corpor sustain report mask evolut organ sustain initi thu fulli understand environment perform organ essenti examin experi specif project relat corpor sustain base case studi green project differ organ difficult determin environment impact project priori case environment consider includ initi project scope instead decis integr environment favor element project dynam occur interact compet institut logic organiz ident creat window opportun individu agenc window individu engag reinforc microprocess support tradit practic invok enabl microprocess facilit green decision mak consist ecosystem logic process model develop paper provid new perspect tempor contextu dimens environment championship behavior shed light puzzl result organ strong environment orient continu struggl deliv project strong posit environment impact
49;earlier report summar crop yield loss variou north american region weed left uncontrol offer report current wssa weed loss committe potenti yield loss weed base data collect variou region unit state canada dri bean yield loss estim compar dri bean yield weedi control plot weed control research studi conduct dri bean grow region unit state canada year period result field studi show dri bean grower idaho michigan montana nebraska north dakota south dakota wyom ontario manitoba potenti lose averag dri bean yield respect equat monetari loss million respect best agronom practic use weed manag tactic base censu data averag yield loss north america uncontrol weed dri bean product unit state canada reduc kg valu approxim million respect studi document dramat yield monetari loss dri bean weed interfer import continu fund weed manag research minim dri bean yield loss
50;recent advanc single molecule bas superresolut microscopi possibl visual biolog structur unpreced spatial resolut determin spatial coorgan structur cell physiolog patholog condit import biolog goal goal stymi current limit carri superresolut microscopi multipl color here develop approach simultan multicolor superresolut imag reli sole fluorophor excit fluoresc emiss properti modul intens excit laser differ frequenc color channel determin base fluorophor s respons modul excit use frequenc multiplex reduc imag acquisit time multicolor superresolut dna paint maintain advantag minim color cross talk minim photobleach maxim signal throughput abil maintain fluorophor densiti imag color abil use camera field view refer imag modal frequenc multiplex dna paint fm dna paint short frequenc multiplex fulli compat storm superresolut imag term fm storm unlik fm dna paint fm storm prone color cross talk overcom caveat develop machine learn algorithm correct color cross talk accuraci need prior inform imag structur
51;sever acut respiratori syndrom coronaviru sars cov identifi china decemb determin coronaviru diseas covid viru present itali earlier autochthon covid case diagnos uncertain aim identifi anti sars cov antibodi sera collect th novemb th march order assess possibl spread viru itali earlier offici nation diagnosi anti sars cov antibodi evalu retrospect serum sampl patient liver diseas hep pati blood donor bd use rapid serolog test confirm valid chemoluminesc assay rapid test igg posit igm posit case hep pati group two igg posit igm posit case detect bd group chemoluminesc confirm igg posit hep pati bd igm posit hep pati rnaemia detect subject render risk transfus transmiss neglig result suggest earli circul sars cov itali covid case describ china rapid test multipl benefit howev confirm assay requir avoid fals posit result
52;emerg nanotechnolog key enabl technolog past year open avenu new innov applic nanomedicin busi aspect nanomedicin market estim worth usd billion percept market growth usd billion despit opportun underli challeng futur engin nanomateri enm nanomedicin research signific obstacl bring enm clinic stage challeng includ capabl design bias fre method evalu enm toxic lack suitabl detect inconsist character techniqu therefor literatur review state of the art engin nanomateri nanomedicin toxicolog issu work framework develop toxicolog benchmark technic character techniqu determin toxic enm report literatur explor
53;mating fertil success fecund influenc sexual interact individu natur frequenc vari differ environ extent local adapt adult fit compon poorli understood allow popul drosophila melanogast independ evolv mate environ alter sexual interact involv enforc monogami permit polygami structur simpl standard fli vial larger cage ad complex adult male femal reproduct fit measur gener respect reciproc transplant male reciproc local adapt observ monogami simpl polygami treatment consist evolut reproduct competit male polygami perform poorli monogami harm mate howev male evolv complex polygami treatment perform similarli better male mate environ consist previou result show higher genet qualiti treatment differ femal fit mute suggest select femal diverg mate treatment echo common pattern greater phenotyp express diverg male femal
54;mitochondri plastid genom land plant exhibit slowest rate sequenc evolut observ eukaryot genom suggest except abil prevent correct mutat howev mechan respons extrem fidel remain unclear test seven candid gene involv cytoplasm dna replic recombin repair polia polib msh reca ung fpg ogg effect mutat rate model angiosperm arabidopsi thaliana appli highli accur dna sequenc techniqu duplex sequenc detect newli arisen mitochondri plastid mutat low heteroplasm frequenc disrupt msh but candid gene lead massiv increas frequenc point mutat small indel chang mutat spectrum mitochondri plastid dna use droplet digit pcr transmiss novo heteroplasmi gener msh mutant confirm contribut herit mutat rate dual target gene enigmat lineag mut mismatch repair famili present outsid green plant multipl eukaryot group stramenopil alveol haptophyt cryptomonad certain bacteria virus msh previous shown limit ectop recombin plant cytoplasm genom result point broader role recognit correct error plant mitochondri plastid dna sequenc lead greatli suppress mutat rate initi double strand break repair pathway base faith homolog recombin
55;rel littl known immigr settlement experi small mid siz canadian citi includ access local servic hous experi outcomes both key factor success integr studi consid immigr settlement experi includ access local servic hous experi outcom citi kelowna kamloop focu hous rental market relianc commun servic result studi includ recommend improv immigr settlement integr urban area interior british columbia survey data gather april august recent immigr renter citi kelowna kamloop find suggest immigr hous difficult anticip larg unexpectedli high cost unfamiliar canadian hous system immigr citi reli local commun organ government sponsor one place live and or job arriv kelowna kamloop did help immigr reli famili friend initi assist prefer receiv inform prior arriv recommend settlement hous servic offer direct assist new immigr polici succeed attract retain immigr citi british columbia s interior depend presenc a subsidized afford hous b job opportun match immigr qualif offer adequ incom c qualiti servic program integr new immigr commun
56;paper report new research time natur post glaci environment chang lake flixton north yorkshir uk previou investig indic success wetland environ earli holocen ultim infil basin ca cal bp expans wetland environ earli holocen woodland develop link chang human occup landscap mesolith ca cal bp howev understand time natur environment chang palaeolak poor make difficult correl known pattern mesolith activ paper provid new record chronolog charact environment chang lake flixton discuss implic mesolith occup surround landscap
57;protein compris domain limit suit protein famili domain rearrang variou combin gene fusion event evolv new protein function includ acquisit protein allosteri incorpor regulatori domain enzym deoxy d arabino heptuloson phosphat synthas dah p enzym aromat amino acid biosynthesi display divers rang alloster mechan dah pss adopt common architectur share β α catalyt domain attach act lik chorism mutas regulatori domain oper distinct mechan respect domain confer alloster regul control dah p function respons ligand tyr prephen start contemporari dah p protein protein chimera creat interchang regulatori domain engin protein catalyt activ deliv new function allosteri switch ligand specif alloster mechan deliv nonhomolog regulatori domain interchang protein domain repres effici method engin allosteri multidomain protein creat new bifunct enzym
58;hypoxia induc oxid stress main mechan myocardi injuri frequent result cardiomyocyt death precipit life threaten heart failur propofol diisopropylphenol use sedat patient surgeri shown strongli affect regul physiolog process includ hypoxia induc oxid stress howev exact mechan unclear express lrpprc slirp bcl propofol treatment measur rt qpcr western blot analys effect propofol hypoxia determin assess mitochondri homeostasi mitochondri function includ atp level mitochondri mass autophagy mitophagi measur detect presenc lc b autophagosom observ transmiss microscopi propofol treatment inhibit cleav caspase caspase indic inhibitori role mitochondrial rel apoptosi propofol treatment transcript activ lrpprc mitochondrial associ protein exert multipl function maintain mitochondri homeostasi manner depend presenc hypoxia induc factor hif α transcript activ h c primari rat cardiomyocyt lrpprc induc propofol maintain mitochondri membran potenti mmp promot mitochondri function includ atp synthesi transcript activ furthermor lrpprc induc propofol contribut partial inhibit apoptot cell death induc hypoxia taken togeth result indic lrpprc protect antioxid effect maintain mitochondri homoeostasi induc propofol provid new insight protect mechan propofol oxid stress
59;covid pandem continu formul target polici intervent inform differenti sever acut respiratori syndrom coronaviru sars cov transmiss dynam vital import nation region govern develop individual level model sars cov transmiss account location depend distribut age household structur comorbid use distribut age stratifi contact matric instanti specif model hubei china lombardi itali new york citi unit state use data report death obtain posterior distribut unknown paramet infer differ progress epidem locat examin role transmiss particular age group total infect death effect limit contact particular age group vari locat indic strategi reduc transmiss tailor base population specif demographi social structur find highlight role between popul variat formul polici intervent popul though target salutari shelter singl age group substanti curtail transmiss combin adopt physic distanc measur rest popul
60;inhibitor renin angiotensin ra wide use treat hypertens use mice harbor fluoresc cell lineag tracer single cel rna seq long term inhibit ra mice human delet renin inhibit ra lead concentr thicken intraren arteri arteriol sever diseas caus multiclon expans transform renin cell classic endocrin phenotyp matrix secretori phenotyp cell surround vessel wall induc accumul adjac smooth muscl cell extracellular matrix result blood flow obstruct focal ischemia fibrosi ablat renin cell condit delet β integrin prevent arteriolar hypertrophi indic renin cell respons vascular diseas given find prospect morpholog studi human necessari determin extent renal vascular damag caus widespread use inhibitor ra
61;assess function statu post icu patient use barthel index bi katz index ki assess suitabl popul retrospect longitudin studi public tertiari hospit são paulo brazil patient age year old admit icu treat mechan ventil mv h discharg ward inabl answer bi ki limit neurolog orthopaed condit icu stay day patient transfer hospit die ward analys bi ki score pre icu post icu variat calcul bi ki score compar use analysi base item respons theori irt use degre difficulti discrimin item paramet median age year old median apach ii score median icu stay day median mv durat day bi variat ki variat irt analysi bi consid larger number item differ level difficulti bi ki reveal signific deterior function statu icu discharg irt analysi suggest barthel index better scale katz index assess function statu patient discharg icu present better discrimin abil carri task
62;studi explor consist prefer end of lif care elderli hospit patient primari caregiv predictor consist cross sect correl studi recruit dyad elderli hospit patient primari caregiv medic center central taiwan structur questionnair prefer seven end of lif medic treatment option involv cardiopulmonari resuscit intraven therapi nasogastr tube feed intens care unit blood transfus tracheotomi hemodialysi consist prefer end of lif medic care patient caregiv kappa valu seven life sustain medic treatment rang logist regress show predictor consist prefer treatment were patient sign live odd ratio or p male famili caregiv or p cardiopulmonari resuscit patient visit rel intens care unit or p spous caregiv or p nasogastr tube feed spous caregiv or p caregiv visit intens care unit or p tracheotomi spous caregiv or p caregiv visit intens care unit or p hemodialysi end of lif medic treatment prefer inconsist patient famili caregiv influenc asian cultur natur relationship individu experi implement advanc care plan respect patient s autonomi prefer end of lif care recommend
63;develop evalu effectiveness clin applic eosinophil cation protein myeloperoxidas ecp mpo test paper treatment patient allerg rhiniti ar includ control ar patient enrol allergi clinic renmin hospit wuhan univers total ige specif ige skin prick test spt detect particip ar patient treat oral cetirizin hydrochlorid day ecp mpo test paper result nasal secret smear eosinophil count rhinoconjunct total nasal symptom score tnss qualiti life questionnair rqlq visual analogu scale va serum th th th cytokin chemokin data collect pre post treat ecp concentr nasal secret assess elisa pearson correl test kappa consist test use statist analysi post treat colour grade ecp mpo test paper lower ar patient pre treat grade chromogen grade correl posit ecp concentr eosinophil count nasal secret treatment posit ecp mpo test paper result consist posit spt der p ige der f ige result kappa valu respect pre post treat chromogen grade correl posit tnss r r rqlq r r va r r score ar patient ecp mpo test paper effect detect ecp nasal secret result consist spt der p ige der f ige result chromogen grade reflect symptom sever specif cytokin chemokin level ar patient
64;acalabrutinib select coval bruton tyrosine kinas inhibitor activ chronic lymphocyt leukaemia compar efficaci acalabrutinib obinutuzumab chlorambucil obinutuzumab patient treatment na chronic lymphocyt leukaemia elev tn global phase multicentr open label studi patient treatment na chronic lymphocyt leukaemia academ commun hospit countri elig patient untreat chronic lymphocyt leukaemia age year older older year younger year creatinin clearanc ml min calcul use cockcroft gault equat cumul ill rate scale geriatr score greater addit criteria includ eastern cooper oncolog group perform statu score adequ haematolog hepat renal function patient signific cardiovascular diseas exclud concomit treatment warfarin equival vitamin k antagonist prohibit patient randomli assign central interact voic web respons receiv acalabrutinib obinutuzumab acalabrutinib monotherapi obinutuzumab oral chlorambucil treatment administ day cycl reduc infusion rel reaction acalabrutinib administ cycl obinutuzumab administr oral acalabrutinib administ mg twice day progress diseas unaccept toxic effect occur acalabrutinib obinutuzumab group intraven obinutuzumab given day mg mg mg mg cycl day mg cycl obinutuzumab chlorambucil group intraven obinutuzumab given day mg mg mg mg cycl day mg cycl oral chlorambucil given mg kg day cycl cycl primari endpoint progression fre surviv combination therapi group assess independ review committe crossov acalabrutinib allow patient progress obinutuzumab chlorambucil safeti assess patient receiv dose treatment enrol trial complet studi regist clinicaltrials gov nct sept feb recruit patient assess patient did meet elig criteria patient randomli assign treatment patient assign receiv acalabrutinib obinutuzumab patient assign receiv acalabrutinib monotherapi patient assign receiv obinutuzumab chlorambucil median follow up month iqr median progression fre surviv longer acalabrutinib obinutuzumab acalabrutinib monotherapi compar obinutuzumab chlorambucil median reach acalabrutinib obinutuzumab vs month obinutuzumab hazard ratio hr ci p reach acalabrutinib monotherapi vs month obinutuzumab p estim progression fre surviv month acalabrutinib obinutuzumab ci acalabrutinib monotherapi obinutuzumab chlorambucil common grade higher advers event group neutropenia patient acalabrutinib obinutuzumab group patient acalabrutinib group patient obinutuzumab chlorambucil group all grad infus reaction frequent acalabrutinib obinutuzumab patient obinutuzumab chlorambucil patient grade higher infect occur patient given acalabrutinib obinutuzumab patient given acalabrutinib monotherapi patient given obinutuzumab chlorambucil death occur patient given acalabrutinib obinutuzumab patient given acalabrutinib patient given obinutuzumab chlorambucil acalabrutinib obinutuzumab significantli improv progression fre surviv obinutuzumab chlorambucil chemoimmunotherapi provid chemotherapy fre treatment option accept side effect profil consist previou studi data support use acalabrutinib combin obinutuzumab new treatment option patient treatment na symptomat chronic lymphocyt leukaemia acerta pharma member astrazeneca group r ca to jcb
65;obsess compuls disord ocd longstand debilit psychiatr disord relat level distress famili member patient suffer it famili accommod scale fa ocd help medic personnel clearer deeper understand pattern famili accommod studi aim translat fa thai examin psychometr properti factor analysi particip rel ocd patient demograph data collect complet fas t patient health questionnair phq pictori thai qualiti life ptql thai florida obsess compuls inventori foci t analyz sever scale foci t ocd patient rel particip studi collect medic record examin psychometr properti factor analysi fas t test averag total score fas t rang mean score foci sever scale rel phq ptql foci sever scale ocd patient respect cronbach s coeffici alpha fas t demonstr good intern consist item level cvi scale level cvi excel level spearman s rho fa foci symptom checklist foci sever score phq ptql weakli correl impli accept discrimin valid exploratori factor analysi efa suggest three factor solut particip modif facilit famili accommod scale obsessive compuls disorder interviewer r thai version psychometr reliabl valid measur assess accommod famili member ocd patient
66;previou research determin life satisfact ls implicit assumpt one size fit all is usual assum covari ls everyon western world paper use data long run german socio econom panel estim statist model assess effect commit differ person valu ls person valu question are tradit famili valu pro soci altruist valu materialist money career valu valu link differ behaviour choic substanti effect domain satisfact ls infer link set valu behaviour choic domain satisfact constitut altern recip ls howev absenc direct evid motiv claim panel respond conscious follow recip view enhanc ls result indic effect individu adher tradit famili valu recip altruist valu recip record averag ls materialist valu link averag ls
67;macrophag re educ polar respons myocardi infarct mi m anti inflammatori phenotyp known domin late stage mi mesenchym stem cell msc repres promis tool cell therapi particularli heart relat diseas gener msc induc alter macrophag subtyp m m vitro vivo conjectur hypox condit promot secretom product msc hypoxia induc tgf β express tgf β mediat m macrophag polar anti inflamm angiogenesi infarct area hypothes macrophag undergo advanc m polar exposur msc hypoxia treatment msc deriv hypox condit medium hypo cm promot m phenotyp neovascular tgf β smad pathway addit hypo cm deriv msc improv restor ischem heart attenu cell apoptosi fibrosi amelior microvessel densiti base result propos new therapeut method effect mi treatment use regul macrophag polar bmb report
68;rapid spread sars cov threat health system worldwid led govern acut action enforc social distanc previou studi use complex epidemiolog model quantifi effect lockdown polici infect rate howev reli prior assumpt offici regul here use country specif report daili mobil peopl cellular usag model social distanc data driven model enabl extract lockdown characterist cross observ mortal rate that i time social distanc initi highli correl number death r lockdown strict durat inform ii delay day initi social distanc doubl number death iii immedi respons prolong effect covid death toll
69;cleft lip palat common congenit anomali affect male femal psycholog research cleft lip palat rel littl research explor social context cleft lip palat experi live condit daili basi draw common theme emerg sociolog work explor experi peopl live long term condit uncertainti social relat self esteem self imag biomed concern argu theme use help elucid experi peopl live cleft lip palat framework find qualit studi explor experi peopl live cleft lip palat present result suggest theme account peopl live cleft lip palat common experi peopl live long term condit convers interest area diverg unlik long term condit cleft lip palat degen treatment mean symptom reduc time reflect narr normal endpoint care pathway addit prenat diagnosi mean vast major particip studi born into grew within care pathway implic way cleft lip palat understood provis inform relationship member care team time tempor contextualis impact cleft lip palat social relat self
70;studi past decad highlight function signific intrins disord protein idp conform heterogen inher dynam structur studi idp reli nmr spectroscopi despit idp have characterist make challeng studi use tradit h detect biomolecular nmr techniqu here develop suit d n detect experi advantag slower transvers relax properti n nuclei associ narrow linewidth greater chemic shift dispers compar h c reson d experi describ start aliphat h magnet advantag higher initi polar broadli applic backbon assign protein disord dynam unfavor amid proton exchang rate use experi backbon reson assign complet unstructur regulatori domain residu human transcript factor nuclear factor activ t cell nfatc includ prolin residu locat function import serine prolin sp repeat complet assign nfatc regulatori domain enabl studi phosphoryl nfat kinas pka phosphorylation depend bind chaperon protein nfat provid mechanist insight regul nfat nuclear transloc
71;reablement known restor care support older adult regain maintain independ daili life optim function abil user goal healthcar profession use hands off approach key user involv central reablement logic aim studi explor user involv reablement user perspect begin intervent studi explor qualit design includ themat content analysi data repeat individu semi structur interview user accept reablement intervent servic urban norwegian municip control emerg core compon user hand control time bodi profession balanc draw inner strength control limit retain right make judgement decis dream theme seen posit wait see attitud profession goal user dream desir control schedul activ regain faith one s capac strengthen one s dream go hold dream user involv interpret user set goal over emphas user possess inform profession need set goal consid goal import profession seek facilit profession work base belief compet trust profession s expertis user invit profession co creat process user involv previous defin willing posit attitud reablement activ express differ way reablement logic doe match user understand desir time rethink user involv reablement reablement concept develop further better suit individu serv
72;indirect interact plant speci mediat frugivor anim central popul commun dynam success seed dispers speci depend facilit competit interact heterospecif plant yet empir evid interact scarc avail small spatial scale popul lipid rich fruit known prefer migratori bird test predict competit inferior carbohydrate rich fruit speci the hawthorn crataegu monogyna compar lipid rich co fruit speci mediterranean region bulk seed dispers reli migratori bird assess avian seed dispers rel fruit remov rate absolut term seed dispers magnitud seven hawthorn popul distribut altitudin gradient encompass contrast fruit context hawthorn scarc lowland common midland domin fruit speci highland evid seed dispers reduct interspecif competit lowland popul lipid rich fruit domin besid dna barcod analysi bird dispers seed reveal small subset local frugivor assemblag consum hawthorn fruit lowland commun instead consum hawthorn fruit resembl local frugivor assemblag hawthorn fruit domin frugivor choic limit studi suggest mechan rariti domin plant speci jointli influenc environment constraint here precipit altitudin gradient frugivore medi indirect interact plant hinder facilit seed dispers
73;northeast greenland ice stream negi extend km upstream coast onset near ice divid interior greenland map surfac veloc topographi interior greenland exist accuraci constrain situ observ present result gp map surfac veloc area locat approxim km ice divid near east greenland ice cor project eastgrip deep dril site gp strain net consist pole establish observ year strain net cover area km km includ shear margin ice flow uniform surfac speed approxim ma central flow band longitudin transvers strain rate order a increas order magnitud shear margin compar gp result arctic digit elev model list satellite deriv surfac veloc product order evalu product veloc product determin bia precis veloc compar gp observ smooth veloc product need obtain optim precis best product bia precis ma combin gp result satellite deriv product organ pattern flow topographi emerg negi surfac veloc exce approxim ma relat bedrock topographi
74;assess mitig phosphoru p leach subsurfac drainag system challeng high spatial tempor variat leach mean measur total p leach clayey soil eight year studi period four replic treatment kg ha year shallow autumn tillag sht unfertilis fallow uf convent autumn plough ct structur lime sl ct treatment signific use richards bak flow index distanc factor covari p tendenc lower leach obtain compar sl ct sht p adjust respect combin measur adapt drainag condit clay content differ part field propos p leach approxim halv adjac field ha three year post period compar three year pre period structur lime entir field drainag renov plu structur lime drain backfil
75;studi function divers rang speci ecolog role commun rapidli expand area ecolog given extent ecosystem alter effort shift assess variat function divers landscap goal improv land use manag decis construct workflow creat three dimension surfac map function divers examin chang beetl function divers indiana usa landscap sampl prey wood bor predat beetl speci gradient forest fragment indiana use number function trait literatur sourc captur function role develop newli measur function trait estim trait relev beetl ecolog function unknown easili measur function divers indic fric fdi fdiv feve calcul speci abund function trait use assess chang function divers fragment gradient predict habitat fragment greater neg impact predat beetl function divers prey wood bor function divers landscap metric import function divers wood bor predat beetl commun landscap divis index ldi assess landscap subdivis mean shape index msi measur patch shape complex overal three dimension surfac function divers function divers map indiana landscap reveal beetl function divers greatest minim landscap subdivis opposit predict prey wood bor function divers neg impact ldi predat beetl function divers furthermor predat beetl function divers greater increas msi map predict predat fric highest forest area intact habitat sensit habitat fragment adjac continu forest propos land manag guid reveal landscap appropri maxim function divers multipl commun shift rel abund prey benefici predat beetl function group use three dimension plot map
76;life histori theori state individu fit stage life condit occur previou stage migratori speci reproduct effort breed influenc bodi condit molt schedul self provis migrat individu subsequ season i e carryov effect breed howev current uncertainti understand long dist migrant trade energy demand activ i e breed molt migrat provid evid field experiment reduc parent effort long liv procellariform cori s shearwat calonectri boreali induc failur incub stage treatment control bird track subsequ migrat mean light level immers logger sampl specif feather molt differ period migratori cycl recoveri logger yr later feather use perform stabl isotop analysi sia determin corticosteron level cort mean evalu effect breed effort migratori strategi at sea activ pattern molt pattern level stress experienc bird non breed period did detect differ bird induc failur group success breeder term spatio tempor distribut bird share common forag area studi period time major phenolog event did differ fail bird significantli advanc molt reveal sia fli activ pattern stress level fail bird infer cort concentr feather consist lower success breeder end breed non breed period thu provid robust evid cost reproduct physiolog mediat breed non breed period molt schedul cort level howev fail detect clear effect migratori behavior subsequ breed success suggest cost breed long liv speci rapidli buffer post breed period expect life histori theori
77;differenti respiratori infect caus sars cov respiratori pathogen covid outbreak wuhan simultan test sars cov pathogen associ cap determin incid impact respiratori coinfect covid patient includ patient diagnos covid rt pcr use detect influenza a influenza b respiratori syncyti virus chemiluminesc immunoassay use detect igm antibodi adenoviru chlamydia pneumonia mycoplasma pneumonia serum patient base result divid patient group simpl sars cov infect group coinfect sars cov group coinfect patient categor have coinfect viral pathogen coiv coinfect atyp bacteri pathogen coiab statist signific differ age gender time taken return neg sars cov nucleic acid test result length hospit stay mortal simpl sars cov infect group coinfect group hospit covid patient test posit respiratori pathogen addit sars cov pathogen detect earli st week symptom onset identifi week detect cap pathogen c pneumonia follow respiratori syncyti viru m pneumonia adenoviru patient coinfect viral pathogen coiv n longer hospit stay compar patient coinfect atyp bacteri pathogen coiab n fatal remain coinfect patient recov favour outcom coinfect covid patient common coinfect pathogen detect variabl interv covid diseas cours remain import consider target treatment strategi covid patient
78;pharmaci recogn import educ health dispar cultur compet hdcc decad recent emphasi incorpor equiti divers inclus edi pharmaci program institut identifi need incorpor programmat approach hdcc educ meet grow need divers popul pharmaci curricula continu lack holist programmat approach ever doctor pharmaci pharmd student graduat knowledg valu skill provid cultur appropri care divers patient popul commentari advoc holist programmat approach integr hdcc educ serv action curricular develop hope commentari set foundat addit scholarli work recommend regard programmat approach
79;increas evid demonstr microrna regul develop cartilag osteogenesi mir particip develop human articular cartilag remain larg unknown studi aim investig role mir human chondrocyt express mir initi assess human osteoarthr oa tissu articular chondrocyt quantit real tim polymeras chain reaction effect mir prolifer apoptosi human chondrocyt assess dimethylthiazol yl diphenyltetrazolium bromid mtt annexin v fluorescein isothiocyan fitc propidium iodid pi doubl stain assay then effect mir type ii collagen alpha col a aggrecan runt rel transcript factor runx matrix metalloproteinase mmp examin quantit real tim polymeras chain reaction western blot analysi mir significantli increas human oa tissu chondrocyt mir significantli inhibit prolifer chondrocyt promot apoptosi express col a aggrecan dramat decreas express runx mmp significantli increas mir overexpress mir particip cartilag degrad oa manipul express mir human chondrocyt novel therapeut strategi treatment oa
80;reproduc key tenet scientif process dictat reliabl gener result method complex ecolog observ data present novel challeng satisfi need reproduc transpar ecolog system dynam heterogen interact numer factor sculpt natur histori investig complet control observ highli depend spatial tempor context make difficult reproduc comput reproduc achiev comput reproduc refer abil produc equival analyt outcom data set use code softwar origin studi code workflow share author editor provid transpar reader allow research build directli effici primari work qualiti especi import ecolog applic import controversi implic scienc manag polici expect comput reproduc transpar shift rapidli scienc work highlight uniqu challeng ecolog practic guidelin reproduc transpar ecologist continu particip stewardship critic environment inform ensur research method demonstr integr
81;trauma rel cognit self world identifi mediat posttraumat stress disord ptsd chang prolong exposur pe therapi howev extent neg cognit mediat ptsd chang ptsd treatment unclear addit previou studi test altern mediat ptsd chang pe sampl treatment seek active duti militari personnel ptsd present studi examin specif neg cognit mediat effect pe present cent therapi pct addit examin possibl mediat cognit emot regul lag mediat analys indic neg cognit self world unhelp cognit emot regul strategi catastroph significantli mediat chang ptsd baselin month follow up combin model mediat effect catastroph greater neg cognit world similar neg cognit self moder mediat analys reveal effect catastroph greater pe pct find trauma rel cognit and greater degre emot regul strategi catastroph mediat ptsd chang research need determin mediat variabl repres mechan therapeut chang
82;identifi relationship clinic assess chronic pain enabl gener multivari model predict patient satisfact spinal cord stimul sc treatment data exploratori clinic trial sub percept sc spsc review forty seven subject test multipl spsc program day each end program period subject record pain intens patient satisfact treatment pswt modifi patient global impress chang physic activ toler time outcom variabl evalu pearson s correl coeffici use assess pair wis correl multigener mix effect model perform creat model best explain relationship variabl final model gener predict pswt use even pain intens epi interact epi walk toler time mix effect model allow visual interact epi walk toler time patient satisfact sc patient cent outcom desir evalu complex multidimension health impair accur predict patient satisfact treatment remain challeng understand variabl predict either causat associ satisfact use clinician result studi suggest composit measur activ toler i e walk toler pain intens predict patient satisfact sc therapi studi highlight util composit outcom metric evalu benefit sc chronic low leg pain
83;patient multipl sclerosi ms increasingli demand access reliabl inform regard diseas object infoseek m studi assess strategi peopl ms use search inform diseas includ sourc frequenc reliabl prefer content non intervent cross sect studi conduct patient diagnosi ms accord mcdonald criteria includ infoseek questionnair use assess patient strategi seek inform diseas clinic characterist variabl includ disabl qualiti life fatigu cognit anxieti depress analys use expand disabl statu scale edss multipl sclerosi impact scale msis item modifi fatigu scale mfis symbol digit modal test sdmt hospit anxieti depress scale had respect patient studi mean age year femal mean diseas durat year relapsing remit ms mean edss score internet either mobil comput frequent report sourc inform lifestyle rel inform research emerg treatment symptom control share experi patient diseas prognosi search topic neurologist nurs trust sourc inform younger patient higher sdmt score associ search resourc m m respect frequenc search relat number relaps r edss r msis physic psycholog compon r invers depress r healthcar profession consid reliabl sourc inform peopl ms search inform internet frequent individu inform strategi consid differ factor involv need
84;recent studi shown relationship triglycerid glucos tyg index risk stroke gener popul patient cohort howev role tyg index stroke risk elderli hypertens patient determin thu aim investig associ tyg index stroke ischem stroke elderli individu hypertens includ elderli subject hypertens china h type hypertens registri studi current analysi tyg index calcul ln fast triglycerid mg dl fast glucos mg dl outcom stroke ischem stroke median follow up year stroke diagnos patient ischem stroke diagnos patient multivari cox proport hazard model reveal tyg index posit associ risk stroke per unit increment hr ci ischem stroke hr ci tyg index assess quartil significantli higher risk stroke hr ci ischem stroke hr ci particip quartil compar quartil tyg index potenti use earli identif elderli hypertens patient high risk experienc stroke
85;recess loss of funct mutat atp a park associ spectrum neurodegen disord includ parkinson s diseas pd recent reveal late endo lysosom transport atp a pump polyamin like spermin cytosol atp a dysfunct caus lysosom polyamin accumul ruptur here investig atp a provid protect mitochondri toxin rotenon environment pd risk factor rotenon promot mitochondrial gener superoxid mitoro exacerb atp a defici sh sy i cell patient deriv fibroblast disturb mitochondri function induc toxic cell death moreov atp a knockdown induc atf chop depend stress respons follow rotenon exposur mitoro atf chop block mitotempo mitochondri antioxid suggest impact atp a mitoro relat antioxid properti spermin pharmacolog inhibit intracellular polyamin synthesi α difluoromethylornithin dfmo increas mitoro atf atp a defici polyamin transport activ atp a requir lower rotenone dfmo induc mitoro exogen spermin quench rotenone induc mitoro atp a interestingli fluoresc label spermin uptak mitochondria drop consequ atp a transport defici cellular observ recapitul vivo caenorhabd elegan strain defici atp a ortholog catp anim exhibit basal elev mitoro level mitochondri dysfunct enhanc stress respons regul atfs c elegan ortholog atf caus hypersensit rotenon revers mitotempo togeth studi reveal conserv cell protect pathway counter mitochondri oxid stress atp a medi lysosom spermin export
86;health rel qualiti life qol defin patient s subject percept health insuffici data exist qol patient undergo hallux valgu hv oper use item short form survey sf measur qol patient aim evalu effect hv qol identifi qol determin patient underw surgeri hv includ studi sf questionnair appli patient surgeri patient medic record examin identifi possibl factor affect qol age gender bodi mass index durat symptom smoke mean age patient year patient women mean durat diseas year surgeri improv qol score gener health emot well b role limit person emot problem physic function bodili pain howev chang score vital social function statist signific lower postop qol score emot well b bodili pain significantli associ age durat symptom compar mean qol healthi adult turkish popul score subdimens lower studi show hv adult neg impact gener health bodili pain physic function physic emot well b social well b vital
87;serum amyloid saa acut phase inflammatori protein previous describ robust biomark colorect inflamm patient ulcer coliti uc clinic remiss howev induc saa express uc remain unclear studi demonstr saa significantli express intestin tract uc mous model compar c reactiv protein inflammatori biomark moreov interleukin tumor necrosi factor α promot saa express toll lik receptor ligand flagellin lipopolysaccharid furthermor result suggest nuclear factor kappa b nf κb pathway involv promot saa express flagellin inhibit treatment aminosalicyl acid asa therefor flagellin nf κb saa axi repres mechan asa suppress intestin inflamm
88;follow allopolyploid format extens genom evolut occur eventu loss homeolog gene copi process diploid occur time independ evolutionari forc determin probabl rate gene loss remain poorli understood here conduct genom transcriptom sequenc broad sampl chines access capsella bursa pastori recent form allotetraploid genom data reveal group access eastern group low altitud region western group high altitud region differenti northwestern group popul differenti total express limit close relat popul contrast rel express homeolog copi close mirror genome wid snp diverg consist thi observ neg correl express chang homeologu howev gene show popul genom evid adapt evolut enrich express diverg homeologu provid clear evid adapt shift rel gene express overal pattern suggest neutral drift contribut popul differenti express homeologu drive eventu gene loss longer period time
89;lack evid regard chronic diseas modifi risk factor prison popul latin america purpos studi estim preval modifi risk factor chronic diseas assess relationship length incarcer analys data cross section studi prison randomli select answer questionnair socio demograph health behaviour content use audio computer assist self interview format physic activ pa low qual diet current smoke alcohol cocain use month prison main outcom quantil regress model logist regress model perform final analyt sampl consist prison mexico citi prison pa estim median metabol equivalents min week preval alcohol use cocain use current smoke result suggest that length incarcer increas pa alcohol cocain use increas qualiti diet decreas studi support hypothesi exposur prison environ measur length incarcer foster modifi risk factor chronic diseas particularli diet qualiti cocain use
90;reduc β cell function insulin defici hallmark diabet mellitu accompani malfunct glucagon secret α cell insulin therapi develop treat insulin defici on demand supplement glucagon acut hypoglycemia treatment remain inadequ here transderm patch mimic inher counterregulatori effect β cell α cell blood glucos manag dynam releas insulin glucagon modul share copolymer matrix compris differ ratio key monom dualli respons hyper hypoglycem condit type diabet mous model hybrid patch effect control hyperglycemia minim occurr hypoglycemia set insulin therapi simul delay meal insulin overdos
91;injuri occur neonat period mammal known induc plastic pain pathway lead pain dysfunct later life effect uniqu mammalian nervou understood here investig similar effect early lif injuri large brain compar model cephalopod euprymna scolop peripher nervou e scolop undergo profound perman plastic injuri peripher tissu earli post hatch period injuri given later juvenil period addit innat defens behaviour learn impair injuri earli life suggest similar pattern nervou behaviour remodel occur squid mammal indic adapt valu long last plastic aris early lif injuri suggest injuri inflict earli life signal nervou environ highli danger thu neonat pain plastic conserv pattern purpos set develop nervou system s baselin respons threat articl theo murphi meet issu evolut mechan behaviour import pain
92;side effect normal tissu reduc therapeut window radiotherapi radiotherapi skin inevit expos dose ioniz radiat lead vari degre skin damag natur antioxid explor radioprotect potenti thu present studi aim investig protect effect curcumin radiotherapy induc oxid damag skin rat divid group follow vehicl control without irradi drug treatment treatment mg kg curcumin gy singl dose irradi onli mg kg curcumin plu gy radiat rc treatment group rat treat oral mg kg curcumin day irradi consecut day irradi week irradi rat sacrif skin tissu collect frozen c determin malondialdehyd mda catalas cat superoxid dismutas sod glutathion peroxidas gsh px activ skin tissu radiotherapy induc oxid injuri skin evidenc elev mda level deplet cat sod gsh px activ howev administr curcumin irradi prevent radiotherapy induc oxid damag significantli elev activ antioxid enzym find present studi curcumin show potenti protect radiotherapy induc oxid injuri skin howev futur studi requir evalu clinic efficaci
93;root growth strategi critic seed surviv establish dri condit strategi plastic littl known aim document abil young grass seedl adjust root architectur root morpholog biomass alloc root promot water uptak surviv progress drought seedl grow column fill sand expos drought well wat control repeatedli harvest determin biomass fraction root length architectur morpholog greenhous experi allometr scale expon standardis major axi regress use investig alloc pattern young seedl abl sustain leaf turgor function week progress drought phenotyp plastic primari root produc deeper simpler root biomass alloc root decreas did respond compon root morpholog show moder plastic result suggest morpholog architectur plastic primari root key featur dehydr avoid surviv grass seedl moder drought alloc biomass root develop secondari root constrain
94;evid show qualiti report randomis control trial optim lack transpar report imped reader judg reliabl valid trial find prevent research extract inform systemat review result research wast consolid standard report trial consort statement develop improv report randomis control trial primari focu statement parallel group trial treatment group crossov trial particular type trial chronic condit particip randomis sequenc intervent use effici design particip act control howev report crossov trial variabl incomplet hinder use clinic decis make futur research present consort extens randomis crossov trial aim facilit better report crossov trial consort checklist revis crossov design introduc modifi flowchart baselin tabl enhanc transpar exampl good report evid base rational consort crossov checklist item provid
95;review recent exampl data analysi g formula power tool analyz longitudin data surviv analysi specif focu common choic time scale review inferenti issu aris research increasingli engag question requir time scale subject left trunc right censor assumpt necessari allow right censor defin literatur similar assumpt left trunc defin polici biolog consider dictat observ data analyz time scale subject left trunc age consider left trunc need especi biolog polici consider dictat age relev time scale interest methodolog develop need reduc potenti bia left trunc occur
96;chronic postsurg pain cpsp common patient receiv major surgeri cpsp produc suffer patient physic mental howev mechan underli cpsp remain elus here genome wid express profil ipsilater spinal cord dorsal horn scdh perform identifi potenti gene relat cpsp rat skin muscl incis retract smir model establish induc cpsp immunostain use studi glial cell neuron activ ipsilater scdh smir model rat rna sequenc rna seq combin bioinformat analysi undertaken explor gene express profil qpcr appli valid express repres gene smir model rat develop persist mechan allodynia ipsilater hindpaw day ipsilater scdh smir rat show remark glial cell neuron activ number differenti express gene deg identifi ipsilater scdh smir rat rna seq qpcr confirm express repres deg bioinformat indic chemic synapt transmiss sensori percept pain neuroact ligand receptor interact predomin function compar dataset human pain rel gene gene exclus particip pain modul mechan studi provid novel understand molecular mechan possibl contribut cpsp find offer new target futur treatment cpsp
97;hemagglutin inhibit hai assay establish correl protect inactiv influenza vaccin howev proport vaccine induc protect mediat post vaccin hai titer assess use data random placebo control trial split virion inactiv influenza vaccin children age year sera collect day receipt vaccin placebo test hai assay b brisbane lik b victoria lineag fit cox proport hazard model time laboratory confirm influenza b use causal mediat analysi estim proport total effect vaccin mediat higher hai titer estim vaccin efficaci confirm b victoria infect confid interv post vaccin hai titer explain effect vaccin protect major effect inactiv influenza vaccin children mediat increas hai titer vaccin howev compon immun respons vaccin play role protect explor causal mediat analysi provid framework quantifi role variou mediat protect
98;studi report post occup evalu perform social hous complex consist apart symptom damag produc high moistur level need investig result knowledg special project design mass produc social hous larg cost repair reduc appli measur avoid moistur problem indoor environ evalu perform stage indic investig diagnost process map data store use bim standard use stakehold action indic stage data collect questionnair survey quick evalu conduct affect unit investig stage analysi entir build complex conduct simul test build energi standard diagnost stage in situ laboratori measur use calcul result factor involv moistur damag main caus overcrowd space inadequ thermal regul local climat poor apart complex design flaw inconsist qualiti construct
99;fluctuat signal transduct pathway frequent observ mammalian develop howev role regul stem cell explor track spatiotempor erk mapk dynam human epiderm stem cell stem cell differenti cell distinguish high low stabl basal erk activ respect cell pulsatil erk activ transit basalhi pulselo stem basalhi pulsehi basalmid pulsehi basallo pulselo differenti cell occur expand keratinocyt coloni respons differenti stimuli pharmacolog inhibit erk induc differenti cell basalmid pulsehi state basal erk activ puls differenti regul dusp dusp lead specul dusp medi erk puls down regul promot initi differenti dusp medi down regul mean erk activ promot stabil postcommit differenti level mapk mapk transcript correl dusp dusp transcript individu cell suggest erk activ neg regul transcript posttransl mechan cell cultur topographi mimic epidermal derm interfac spatial segreg mean erk activ puls observ vivo imag mous epidermi reveal pattern distribut basal cell pulsatil erk activ down regul link onset differenti find demonstr erk mapk signal fluctuat link kinas activ stem cell dynam
